Gonzalez-Rey_2012_Environ.Pollut_173C_200

Reference

Title : Does selective serotonin reuptake inhibitor (SSRI) fluoxetine affects mussel Mytilus galloprovincialis? - Gonzalez-Rey_2012_Environ.Pollut_173C_200
Author(s) : Gonzalez-Rey M , Bebianno MJ
Ref : Environ Pollut , 173C :200 , 2012
Abstract :

Fluoxetine (FLX) the active pharmaceutical ingredient (API) in Prozac((R)) is a widely prescribed psychoactive drug which ubiquitous occurrence in the aquatic environment is associated to a poor removal rate in waste-water treatment plant (WWTP) systems. This API acts as a selective serotonin reuptake inhibitor (SSRI) frequently reported to cause disrupting effects in non-target species. The objective of this study includes a multibiomarker response evaluation on mussel Mytilus galloprovincialis during two weeks exposure to 75 ng L(-1) FLX assessing antioxidant enzymes activities - superoxide dismutase (SOD), catalase (CAT) and glutathione-S-transferase (GST); lipid peroxidation (LPO), acetylcholinesterase (AChE) neurotoxic response and endocrine disruption through alkali-labile phosphates (ALP) indirect measurement of vitellogenin-like proteins. Results show transient tissue-specific enzymatic responses and damage affecting mostly mussel gills. However, the clear ALP levels inhibition throughout time in both sex-differentiated gonads gives evidence to FLX reinforced action as an endocrine disruptor rather than an oxidative or neurotoxic inducer.

PubMedSearch : Gonzalez-Rey_2012_Environ.Pollut_173C_200
PubMedID: 23202651

Related information

Citations formats

Gonzalez-Rey M, Bebianno MJ (2012)
Does selective serotonin reuptake inhibitor (SSRI) fluoxetine affects mussel Mytilus galloprovincialis?
Environ Pollut 173C :200

Gonzalez-Rey M, Bebianno MJ (2012)
Environ Pollut 173C :200